Pumafentrine

N/A

Report date: 2024/07/12 10:36:16

NME

Base Information

Drug NamePumafentrine

Drug Alias NameBY-343

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionPhosphodiesterase 3 inhibitorsPhosphodieterase 4 inhibitors

TargetsPhosphodiesterase 3Phosphodieterase 4

Therapy Area/IndicationsPulmonary Disease, Chronic ObstructiveAsthma

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusDiscontinued (Phase 2 Clinical)

Highest Status in ChinaN/A

Originator CompaniesAltana Inc

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesAltana Inc

Active IndicationsN/A

Inactive IndicationsPulmonary Disease, Chronic ObstructiveAsthma

ATC CodeN/A